FN2 Earnings Intelligence
Merck & Co., Inc. ratios (quarterly)
Merck & Co., Inc. (MRK) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $8,629 | $8,007 | $18,169 | $5,327 | $6,849 | - | - |
| + Debt | $34,844 | $35,402 | $41,374 | $49,117 | $53,906 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $15,529 | $15,806 | $17,276 | $16,286 | $16,607 | $17,321.1 | $16,900.9 |
| % Growth | - | - | - | - | - | 0.3% | - |
| Gross Profit | $12,110 | $12,249 | $13,421 | $12,091 | $12,212 | - | - |
| % Margin | 78.0% | 77.5% | 77.7% | 74.2% | 73.5% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $5,079 | $4,427 | $5,785 | -$4,240 | -$1,335 | - | - |
| % Margin | 32.7% | 28.0% | 33.5% | -26.0% | -8.0% | - | - |
| Diluted EPS | $2.01 | $1.76 | $2.32 | -$1.72 | -$0.54 | $2.22 | $1.96 |
| % Growth | - | - | - | - | - | -4.5% | - |
| Operating Cash Flow | $2,500 | - | - | $3,918 | - | - | - |
| CapEx | $1,328 | - | - | $991 | - | - | - |
| Free Cash Flow | $1,172 | - | - | $2,927 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $15,529 | $15,806 | $17,276 | $16,286 | $16,607 | $17,321.1 | $16,900.9 |
| Gross Profit | $12,110 | $12,249 | $13,421 | $12,091 | $12,212 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $5,079 | $4,427 | $5,785 | -$4,240 | -$1,335 | - | - |
| Diluted EPS | $2.01 | $1.76 | $2.32 | -$1.72 | -$0.54 | $2.22 | $1.96 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $8,629 | $8,007 | $18,169 | $5,327 | $6,849 |
| Short-term Debt | $1,360 | $1,434 | $1,405 | $2,444 | $2,825 |
| Long-term Debt | $33,484 | $33,968 | $39,969 | $46,673 | $51,081 |
| Total Debt | $34,844 | $35,402 | $41,374 | $49,117 | $53,906 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2,500 | - | - | $3,918 | - |
| Capital Expenditure | $1,328 | - | - | $991 | - |
| Free Cash Flow | $1,172 | - | - | $2,927 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 78.0% | 77.5% | 77.7% | 74.2% | 73.5% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 32.7% | 28.0% | 33.5% | -26.0% | -8.0% |
| FCF Margin | 7.5% | - | - | 18.0% | - |
| Diluted EPS Growth | - | - | - | - | - |